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What’s Known on This Subject
Diagnosis of LTBI in children is clinically relevant; however, the standard TSTmight have
false-negative results in this age group. IGRAs hold promise to be more accurate than
the skin test.
What This Study Adds
Different IGRAs perform differently, particularly among children 4 years of age, in
terms of rates of indeterminate results: the ELISA-based assays are negatively affectedby
younger age compared with the ELISPOT-based test.
ABSTRACT
BACKGROUND. The accurate diagnosis of latent tuberculosis infection reduces the risk of
progression to severe disseminated disease. However, in young children, a major
limitation of the standard tuberculin skin test is that false-negative results cannot be
detected. The new interferon- release assays QuantiFERON-TB Gold (Cellestis
Carnegie Victoria, Australia), QuantiFERON-TB In-Tube (Cellestis), and T-SPOT.TB
(Oxford Immunotec, Abingdon, United Kingdom) show promise of greater accuracy,
but they may also be affected by impaired cellular immunity, resulting in indeter-
minate results (ie, insufficient response in positive-control wells).
OBJECTIVE. To evaluate the impact of age on the performance of interferon- release
assays when used in a routine hospital setting among children tested for suspected
active or latent TB infection.
METHODS.We retrospectively studied 496 children 0 to 19 years of age who had been
tested with the tuberculin skin test and at least 1 interferon- release assay: 181 with
QuantiFERON-TB Gold and 315 with QuantiFERON-TB In-Tube. In 154 of the
children, paired interferon- release assay testing was available: 87 with QuantiF-
ERON-TB Gold/T-SPOT.TB and 67 with QuantiFERON-TB In-Tube/T-SPOT.TB.
RESULTS.Compared with T-SPOT.TB, the rates of indeterminate results were signifi-
cantly higher for both QuantiFERON-TB Gold and QuantiFERON-TB In-Tube. Quan-
tiFERON-TB Gold and QuantiFERON-TB In-Tube also gave indeterminate results
more frequently in children 4 years of age than in those 4 years of age. Indeter-
minate results were associated with younger age for both QuantiFERON-TB Gold
and QuantiFERON-TB In-Tube but not for T-SPOT.TB. Considering age as a binary
variable (4 and 4 years of age), a significantly higher concentration of phytoh-
aemagglutinin-produced interferon- was observed in older children with both
QuantiFERON-TB Gold and QuantiFERON-TB In-Tube.
CONCLUSIONS.Different blood tests for the diagnosis of latent tuberculosis infection in
children seem to perform differently, because both QuantiFERON-TB tests were
more likely than T-SPOT.TB to give indeterminate results in children 4 years of age. Pediatrics 2009;123:e419–e424
IN YOUNG CHILDREN, the risk of progression from latent tuberculosis infection (LTBI) to active tuberculosis (TB)is inversely related to age; without specific treatment, approximately one half of infants and one fifth of older
children develop active TB up to 2 years after infection.1 In particular, children 4 years of age fail to contain
the spread of intracellular pathogens as a consequence of an impaired T-cell response.2–4 Therefore, this age
group is considered a priority in the strategies to control TB worldwide. The century-old tuberculin skin test
(TST) is still the standard method for diagnosing LTBI, but it has drawbacks, such as low specificity in
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Mycobacterium bovis BCG-vaccinated persons and low
sensitivity among patients with an impaired cellular
immune system.5 Paradoxically, the TST has more
false-negative results in populations with higher risk
of TB reactivation; 10% of children with culture-
confirmed TB do not react to the TST at the time of
diagnosis.1,6
A new generation of LTBI diagnostics, the interfer-
on- (IFN-) release assays (IGRAs), seem to be sig-
nificantly more accurate than the skin test for the
diagnosis of LTBI.3,7,8 Three commercially available
IGRAs have been approved for clinical use by the Food
and Drug Administration. T-SPOT.TB (Oxford Immu-
notec Ltd, Abingdon, United Kingdom) is based on the
enzyme-linked immunospot (ELISPOT) technology,
whereas QuantiFERON-TB Gold (QFT-G) and Quan-
tiFERON-TB Gold In-Tube (QFT-IT) (Cellestis Ltd,
Carnegie Victoria, Australia) are based on the en-
zyme-linked immunosorbent assay (ELISA). These
tests share common features but also have some tech-
nical differences.7 IGRAs have already been shown to
be significantly more specific than the TST,8 and pre-
liminary evidence from 2 recent longitudinal studies
indicates that IGRAs may have higher positive predic-
tive values for development of future TB, compared
with the skin test.9,10 The performance of IGRAs for
diagnosis in children has not been extensively ex-
plored.3,8,11 In particular, the rate of indeterminate
results, that is, an insufficient response in positive-
control wells, is a clinically relevant issue. Few studies
have been published on this topic12–18 and fewer have
explored the relationship between IFN- production
and age.13,16,19 Therefore, we analyzed the performance
of IGRAs under routine conditions in a large pediatric
population to investigate the frequency of indetermi-
nate results and the potential effect of age on these
diagnostic tests.
PATIENTS ANDMETHODS
Study Population
We retrospectively evaluated all patients tested with at
least 1 IGRA at the pediatric department of the Univer-
sity Hospital of Modena (Italy) between January 2004
and July 2007. Testing was performed because of sus-
pected TB infection as a result of recent immigration (2
years), household contact with a person with active
pulmonary TB, or suspected pulmonary or lymph-nodal
TB. Parents of the children consented in advance to have
sensitive clinical data collected for future research. Chil-
dren were tested for clinical purposes with 1 or more
IGRAs, according to the availability of the assays: QFT-G
(alone or combined with T-SPOT.TB) until December
2004 and QFT-IT (alone or combined with T-SPOT.TB)
afterward (Table 1).
Procedures
Demographic and clinical data, including birthplace,
BCG vaccination status (vaccination certificate and/or
the presence of the typical scar), TST result, and reasons
for testing were collected by using standard clinical
forms. All enrolled subjects underwent a TST with 5
tuberculin units of purified protein derivative (Biocine
test PPD, Chiron, Siena, Italy), according to the intrader-
mal Mantoux method. TST results were interpreted by
trained physicians according to current pediatric guide-
lines (ie, the test was considered positive if the skin
induration was 5 mm in diameter in children with
suspected active TB or recent TB contact or 10 mm in
children who were 4 years of age or were tested be-
cause of recent immigration from an area in which TB is
endemic, regardless of BCG status).11,20 Peripheral blood
samples for IGRAs were drawn and transferred within 3
hours to the laboratory, where they were processed by
trained technicians and interpreted according to the rec-
ommendations of manufacturers.
TABLE 1 Characteristics of Various Subgroups of the Study Population
QFT-G only
(n 181)
QFT-G and
T-SPOT.TB
(n 87)
QFT-IT only
(n 315)
QFT-IT and
T-SPOT.TB
(n 67)
T-SPOT.TBa
(n 154)
N 496
Mean age, n (SD) 10.5 (5.9) 10.2 (5.9) 11.5 (5.5) 7.9 (6.4) 9.2 (6.0) 11.1 (5.7)
4 y, n (%) 39 (21.6) 21 (24.1) 65 (20.6) 36 (53.7) 57 (37.0) 104 (21.0)
4 y, n (%) 142 (78.4) 66 (75.9) 250 (79.4) 32 (47.8) 98 (63.6) 392 (79.0)
Boys, n (%) 88 (48.6) 40 (46.0) 124 (39.4) 22 (32.8) 62 (40.3) 212 (42.7)
BCG-vaccinated, n (%) 54 (41.9) 24 (36.9) 139 (49.1) 5 (8.1) 29 (18.8) 193 (38.9)
Reason for testing, n (%)
Recent immigration from area with endemic TB 78 (43.1) 28 (32.2) 126 (40) 3 (4.5) 31 (20.1) 204 (41.1)
Recent contact with a pulmonary TB case 91 (50.3) 49 (56.3) 176 (55.9) 60 (89.6) 109 (70.8) 267 (53.8)
Suspected active TB 12 (6.6) 10 (11.5) 13 (4.1) 4 (6.0) 14 (9.1) 25 (5.1)
Place of birth, n (%)
Africa 47 (26.0) 20 (23.0) 81 (25.6) 7 (10.4) 27 (17.5) 128 (25.8)
Middle East 29 (16.0) 23 (26.4) 34 (10.9) 3 (4.5) 26 (16.9) 63 (12.8)
Eastern Europe 33 (18.2) 13 (14.9) 56 (17.6) 3 (4.5) 16 (10.4) 89 (17.8)
Asia 14 (7.7) 3 (3.4) 17 (5.4) 3 (4.5) 6 (3.9) 31 (6.3)
South America 6 (3.3) 0 (0) 5 (1.6) 0 (0) 0 (0) 11 (2.2)
Western Europe 52 (28.7) 28 (32.2) 122 (38.8) 51 (76.1) 79 (51.3) 174 (35.1)
a From dual tests with a QFT.
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The T-SPOT.TB test was performed on peripheral
blood mononuclear cells separated by centrifugation
from a sample of peripheral venous blood (4 mL for
children 6 years of age and 8 mL for older children).
Peripheral blood mononuclear cells were plated (2.5 
105 cells per well) on a plate precoated with an anti-
IFN- antibody. The test included (1) 2 separate antigen
wells containing either early secretory antigen target 6
(ESAT-6) or culture filtrate protein 10 (CFP10) (Myco-
bacterium tuberculosis–specific antigens); (2) a positive-
control well containing phytohaemagglutinin; and (3) a
negative-control well containing neither mitogen nor
antigen. Plates were incubated overnight at 37°C in an
atmosphere of 5% CO2; after washing, plates were de-
veloped with a conjugate against the IFN- antibody,
and spot-forming units (SFUs) were counted by using an
automated ELISPOT reader (AID, Strassberg, Germany).
SFU values in the negative-control well were subtracted
from SFU values in the mitogen and antigen wells.
If the number of SFUs in the negative-control well
was5, T-SPOT.TB results were defined as (1) positive if
either antigen well had at least 6 SFUs more than the
negative control, regardless of the response in the posi-
tive control; (2) negative if the number of SFUs was 6
in both antigen wells and if the positive-control well
had 20 SFUs; and (3) indeterminate if the positive-
control well had 20 SFUs and both antigen wells had
6 SFUs. Furthermore, if the number of SFUs in the
negative-control well was 6, T-SPOT.TB results were
defined as positive if either antigen well had at least
twice the number of SFUs as the negative control, re-
gardless of the response in the positive control. If the
number of SFUs in the negative-control well was 10,
T-SPOT.TB results were defined as a technical error and
not considered in the statistical analysis.
The QFT-G test consisted of a negative-control well (1
mL of whole blood without antigens or mitogen), a
positive-control well (1 mL of whole blood stimulated
with phytohaemagglutinin), and 2 antigen wells (1 mL
of whole blood in each well) stimulated with ESAT-6 or
CFP10. Whole blood specimens were incubated over-
night at 37°C in a humidified atmosphere. Plasma ali-
quots were harvested, and IFN- concentrations were
determined by using an ELISA with an automated sys-
tem ELISA reader (Dinex Technologies, West Sussex,
United Kingdom) and expressed as IUs. QFT-G results
were defined as (1) positive if the concentration of IFN-
in the antigen well after stimulation with ESAT-6 or
CFP10 was0.35 IU/mL after subtraction of the value of
IFN- in the negative control, regardless of the response
in the positive control; (2) negative if the response to the
specific antigens after subtraction of the value of the
negative-control well was 0.35 IU/mL and the IFN-
concentration in the positive-control well was 0.50
IU/mL; and (3) indeterminate if the concentration of
IFN- in both antigen wells was negative (0.35 IU/mL)
and the value of the positive control was 0.50 IU/mL.
If the concentration of IFN- in the negative-control
well was 2 UI/mL, the test was considered a technical
error and excluded from statistical analysis.
For the QFT-IT test, 1 mL of peripheral venous blood
was collected into each of 3 vacutainer tubes precoated
with either saline (negative control), phytohaemagglu-
tinin (positive control), or ESAT-6, CFP10, and TB7.7.
Results were interpreted as for the QFT-G test, except
cutoff for the negative-control well was set at 8.0 IU/mL.
Statistical Analysis
Binary data were expressed as percentages, continuous
normally distributed data were expressed as means 
SD, and as medians otherwise. Comparisons between
percentages for paired data were conducted by a Mc-
Nemar test, whereas the t test was used for means (for
variables not normally distributed we did compare me-
dians). The association between indeterminate results
and age was evaluated by logistic regression. The esti-
mate of odds ratio (OR) and its relative 95% confidence
interval (95% CI) were calculated. The association be-
tween age and the concentration of phytohaemaggluti-
nin-induced IFN- in both QFT assays or the number of
SFUs in T-SPOT.TB, which were previously log trans-
formed because of their distributional deviation from
normality, was assessed by linear regression. Data were
analyzed for children 4 and 4 years of age based on
increased susceptibility to TB in younger children. Diag-
nostic agreement between tests was assessed by using
Cohen’s  statistics. Level of significance was set to .05.
Analyses were performed by using Stata 10.0 software
(Stata Corp, College Station, TX).
RESULTS
Of 501 children tested, 5 were excluded because of pos-
sible technical errors (ie, high background in the nega-
tive-control well): 2 with QFT-G, 2 with QFT-IT, and 1
with T-SPOT.TB. None of the remaining 496 children
had a known or clinically relevant impairment of cell
immunity or any indication for HIV testing. Character-
istics of the study population are reported in Table 2.
Testing for LTBI
A positive IGRA result was obtained in 34 (18.8%) of the
181 children tested with QFT-G, 54 (17.1%) of the 315
TABLE 2 Characteristics of the Study Population (N 496)
Characteristic Value
Mean age (SD) 11.1 (5.7)
4 y, n (%) 104 (21.0)
4 y, n (%) 392 (79.0)
Boys, n (%) 212 (42.7)
BCG-vaccinated, n (%) 193 (38.9)
Reason for testing, n (%)
Recent immigration from area with endemic TB 204 (41.1)
Recent contact with a pulmonary TB patienta 267 (53.8)
Suspected active TB 25 (5.1)
Place of birth, n (%)
Africa 128 (25.8)
Middle East 63 (12.8)
Eastern Europe 89 (17.8)
Asia 31 (6.3)
South America 11 (2.2)
Western Europe 174 (35.1)
a Fifty-three (19.8%) subjects were also recent immigrants.
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tested with QFT-IT, and 22 (14.3%) of the 154 tested
with both a QFT and T-SPOT.TB test (Table 3). Both
IGRAs showed a lower agreement with the TST in BCG-
vaccinated subjects than in the non-BCG vaccinated
subjects, although the difference was statistically signif-
icant for QFT-G and QFT-IT only (data not shown).
More positive IGRA results were observed among recent
immigrants and those suspected of having active TB,
whereas agreement with the TST was much lower
among recent immigrants (Table 3).
Testing for Response to Mitogen
One hundred eighty-one children were tested with
QFT-G and 315 with QFT-IT. For 154 of the 496 patients,
paired results with T-SPOT.TB were also available: 87
with QFT-G/T-SPOT.TB and 67 with QFT-IT/T-SPOT.TB
(Table 1 and Fig 1). In children with paired tests, inde-
terminate results were significantly more frequent with
QFT-G or QFT-IT than with T-SPOT.TB (12.6% vs 2.3%
[P  .0225] and 16.4% vs 1.5% [P  .0063], respec-
tively).
The rates of indeterminate IGRA results were higher
in children 4 years of age than in children 4 years of
age for both QFT-G (35.9% vs 5.6% [P  .001]) and
QFT-IT (21.5% vs 0.4% [P  .001]), whereas no statis-
tically significant difference was observed for T-SPOT.TB
(1.7% vs 2.0% [P  .895]) (Fig 2). In subjects with
available paired test results, children4 years of age had
indeterminate IGRA results significantly more fre-
quently with QFT-G and QFT-IT than with T-SPOT.TB
(38.1% vs 0% [P .008] and 27.7% vs 2.8% [P .001],
respectively) (Fig 3, upper panel); this difference was not
observed in subjects4 years of age (4.5% vs 3.0% [P
.650] and 3.2% vs 0% [P  .001], respectively) (Fig 3,
lower panel).
The correlation between the frequency of indetermi-
nate results and age, considered as a continuous vari-
able, was statistically significant for both QFT-G (OR:
0.79 [95% CI: 0.69–0.90]) and QFT-IT (OR: 0.68 [95%
CI: 0.52–0.90]), but not for T-SPOT.TB (OR: 0.89 [95%
CI: 0.67–1.18]). These results did not change after ad-
justing for TST results, BCG status, or gender (data not
shown). We also evaluated the correlation between age
and the concentration of phytohaemagglutinin-induced
IFN- response in IGRA positive-control wells, consid-
QFT-G 
(n = 181) 
QFT-IT 
(n = 315) 
QFT-G and TS.TB 
(n = 87) 
QFT-IT and TS.TB 
(n = 67) 
FIGURE 1
IGRA testing in the study population. TS.TB indicates T-SPOT.TB.
FIGURE 2
Rates of indeterminate IGRA results in children4 years of age (black bars) or4 years
of age (white bars)whowere testedwithQFT-G (n 181), QFT-IT (n 315), or T-SPOT.TB
(n 154). FIGURE 3
Rates of indeterminate IGRA results in paired testingof children4 years of age (A) or4
years of age (B). Black columns, QFT-G; gray columns, QFT-IT; white columns, T-SPOT.TB.
TABLE 3 Rates of Positive Results With IGRAs and the TST, CorrelatedWith Reasons for Testing
QFT-G QFT-IT T-SPOT.TBa
n Positive,
n (%)
TST-positive,
n (%)
 n Positive,
n (%)
TST-positive,
n (%)
 n Positive,
n (%)
TST-positive,
n (%)

All 181 34 (18.8) 58 (32.0) 0.43 315 54 (17.1) 74 (23.5) 0.35 154 22 (14.3) 28 (18.2) 0.52
Recent immigrants 78 21 (26.9) 35 (44.9) 0.26 126 39 (30.9) 46 (36.5) 0.16 31 11 (35.5) 13 (41.9) 0.18
Recent TB contact 91 10 (11.0) 18 (19.8) 0.57 176 11 (6.3) 21 (11.9) 0.45 109 5 (4.6) 9 (8.3) 0.69
Suspected active TB 12 3 (25.0) 5 (41.7) 0.60 13 4 (30.8) 7 (53.8) 0.66 14 6 (42.9) 6 (42.9) 0.38
a From dual tests with a QFT.
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ered as both binary and continuous variables. Linear
regression showed that the log-transformed IFN- re-
sponse to phytohaemagglutinin significantly increased
with age in both QFT-G (  .13 [95% CI: 0.10–0.17]
P  .001) and QFT-IT (  .16 [95% CI: 0.14–0.18] P 
.001); on the contrary, the response to log-transformed
IFN- response to phytohaemagglutinin in T-SPOT.TB
significantly decreased with age (  .04 [95% CI: .06
to .01]; P  .005).
Considering age as a binary variable (4 and 4
years of age), a significantly lower concentration of phy-
tohaemagglutinin-produced IFN- was observed among
younger children for both QFT assays, whereas this was
not the case for T-SPOT.TB (Table 4). In addition, signif-
icantly higher concentrations of IFN- were obtained in
the positive-control wells of QFT-IT compared with
QFT-G in all age classes (4 years of age: 5.4 vs 2.1
IU/mL [P  .013]; 4 years of age: 25.6 vs 6.1 IU/mL
[P  .001]) (Table 4). Four of 37 (10.8%) indeterminate
QFT assays were in children with a positive TST: of these,
3 were BCG-vaccinated and 1 was diagnosed with My-
cobacterium avium infection. Among children with an
indeterminate QFT test and available T-SPOT.TB test
(n  23), all but 1 were T-SPOT.TB-negative, and none
was indeterminate with T-SPOT.TB.
Stratification of the results based on the extent of
exposure to M tuberculosis (ie, household or school con-
tacts of smear-positive cases versus casual contacts or
recent immigrants) showed no differences in the rates of
indeterminate results for any assay (QFT-G: P  .924;
QFT-IT: P  .654; T-SPOT.TB: P  .974).
DISCUSSION
Our investigation of the routine use of IGRAs in chil-
dren indicates that the ELISA-based assays (QFT-G
and QFT-IT) are significantly more affected by inde-
terminate results, because of low mitogen response,
than is the ELISPOT-based test (T-SPOT.TB). This dif-
ference is particularly evident in children 4 years of
age and is confirmed by the finding of a statistically
significant inverse relationship between the amount
of IFN- and age for both QFT assays. This phenome-
non was not observed in the T-SPOT.TB assay, in
which significantly higher SFUs values were found in
younger children. Other groups have explored the
issue of IGRA performance in children with partially
contrasting results. Connell et al13 reported a 17%
incidence of indeterminate QFT-G results, which is
similar to our findings. The same group observed a
higher rate of indeterminate results with T-SPOT.TB
than with QFT-IT. However, all of the T-SPOT.TB
assays were invalid owing to high background in the
negative-control well or low-cell counts.18 Mandala-
kas et al17 reported no indeterminate results with ei-
ther QFT-G or T-SPOT.TB in a small cohort of HIV-
infected children, whereas Tsiouris et al21 did not
detect any indeterminate QFT-IT results in children
5 years of age. Our findings, based on a larger sample
size, confirm that indeterminate QFT-IT results in
older children are uncommon. Finally, a recent study
of 227 children between 0 and 15 years of age also
reported a statistically significant correlation between
mitogen response in the QFT-IT assay and age.22 The
variability of such findings across different studies
might be explained by a mix of different factors, in-
cluding the criteria used to define an indeterminate
IGRA result (low mitogen versus high nil), the study
design (“routine” vs “controlled” conditions), and the
population tested (effect of different age groups). Cer-
tainly, this is an area where focused, prospective con-
trolled studies are needed.
QFT-IT and T-SPOT.TB have both been approved for
clinical use by the US Food and Drug Administration,
although with some minor modifications in the inter-
pretation of T-SPOT.TB results, compared with the Eu-
ropean package insert. This reflects the vast amount of
published data available. Therefore, it is predictable that
IGRAs will rapidly become routine in clinical practice. At
that point, differences with the standard TST will be
particularly relevant. One such difference is the 3-way
response of IGRAs (positive, negative, or indeterminate/
invalid), compared with the 2-way response of the TST
test (positive or negative). However, the meaning and
the impact of indeterminate IGRA results in clinical
practice have not been properly evaluated. For now,
these results should caution clinicians to be aware of
potential false-negative results. In addition, although the
difference in the frequency of indeterminate results be-
tween the QFTs and T-SPOT.TB in our study was strik-
ing, the clinical impact of this difference might be rela-
tively small, because almost all indeterminate QFT
results were negative with T-SPOT.TB. Another interest-
ing finding of our study is the significantly higher con-
centration of IFN- produced in QFT-IT compared with
QFT-G. Whether this is a consequence of the in-tube
format or some other technical factor (such as shaking of
tubes), and whether it has an impact on antigen-specific
responses, merits additional attention.
TABLE 4 Concentrations of IFN- in the Positive-Control Wells of
IGRAs
All <4 y >4 y P
QFT-G, n, IU/mL 181 39 142
Median 3.01 1.01 3.73 .0001
Mean 0.86 0.44 1.22 .0001
SD 1.62 1.84 1.36
Mean difference 1.65
QFT-IT, n, IU/mL 315 65 250
Median 3.10 0.75 3.34 .0001
Mean 2.61 0.68 3.11 .0001
SD 1.44 1.56 0.87
Mean difference 2.43
T-SPOT.TB, n, SFUs per well 154 57 97
Median 103 142 87 .0001
Mean 4.65 4.93 4.48 .004
SD 0.94 0.67 1.03
Mean difference 0.45
The minimum amount of IFN- in the positive-control well of QFT assays for a valid result
was 0.50 IU/mL (after subtraction of the nil value). Mean and SD valueswere calculated on
the log scale.
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CONCLUSIONS
Our findings, based on the retrospective evaluation of a
large cohort of children, lend support to the notion that
different IGRAs for the diagnosis of LTBI may produce
significantly different rates of indeterminate results in
young children. In particular, although both QFT for-
mats were negatively affected by young age in terms of
mitogen-stimulated IFN- production, T-SPOT.TB-posi-
tive controls seemed to be equally efficient at any age.
Because young children are a high-risk group and a
main target for preventive LTBI treatment, these results
may have an impact on the strategies aimed at TB con-
trol.
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